How to Fund Your Startup without Giving up Equity: Winning SBIR/STTR Proposals from the NIH

Saturday, December 3, 2016 - 9:00am to 2:00pm
Schiciano Auditorium, Fitzpatrick Center

Raising capital is a central and ongoing challenge for entrepreneurs. Often the entrepreneur must trade his or her valuable equity for needed capital. In healthcare innovation, however, it is often possible to raise non-dilutive capital through the grants from the National Institutes of Health. The Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs are designed specifically to support commercialization of innovative technologies. In this workshop, Dr. Vilkomerson will provide an overview of the proposal process for such grants, share winning and losing proposals, and give insight into the grant review process. Special guests will provide insight into how to integrate academic and entrepreneurial activities. This workshop will highlight common pitfalls to help you improve your chance of success.

Note that this workshop is not sponsored or endorsed by the NIH or any other government agency.

Presenter Bio: David Vilkomerson received a B.S. in Electrical Engineering from MIT and a Ph.D. in Electrical Engineering and Applied Physics from Columbia University. After pioneering work in acoustical holography at RCA Labs, he became Managing Director of Johnson & Johnson’s Special Research Group, where he led the development of the first ultrasonic breast-screening system. He left J&J to start EchoCath, Inc., where he developed ten FDA-cleared commercial ultrasound devices. After that company went public, he left to start a boutique R&D company, DVX, of which he is President. 

DVX has received $7 million from the NIH via 13 SBIR grants. Dr. Vilkomerson’s applications have been successful in obtaining funding at a greater than 85 percent success rate -- rather than the average of around 15 percent.  He has been granted 45 patents, with several more pending.

Lunch provided | RSVP by Nov. 29: